Drug intelligence / Profile preview

eperisone

Development stage
Phase 3
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral
01

Overview

Eperisone is a centrally acting skeletal muscle relaxant and antispasmodic agent. It works by relaxing both skeletal muscles and vascular smooth muscles, leading to reduced myotonia (muscle stiffness), improved circulation, and suppression of the pain reflex. Eperisone inhibits the vicious cycle of myotonia by decreasing pain, ischemia, and hypertonia in skeletal muscles. This alleviates stiffness and spasticity while facilitating muscle movement without significantly reducing muscle power or causing strong sedation compared to other antispasmodics. It is also used to improve dizziness and tinnitus associated with cerebrovascular disorders or cervical spondylosis. The drug is commonly used in rehabilitation settings for conditions such as spastic paralysis due to cerebrovascular disease or spinal cord injury, cervical spondylosis, postoperative sequelae (including after brain or spinal tumor surgery), trauma sequelae (spinal/head injury), amyotrophic lateral sclerosis (ALS), cerebral palsy, spinocerebellar degeneration, spinal vascular diseases and other encephalomyelopathies.

Brand names
Myonal妙纳
Other names
Eperisone hydrochloride盐酸乙哌立松(±)-Eperisone hydrochloride(2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
02

Targets

CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on eperisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eperisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call